Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy

Mandelli, Franco; Avvisati, Giuseppe; Amadori, Sergio; Boccadoro, Mario; Gernone, Angela; Michele Lauta, Vito; Marmont, Filippo; Teresa Petrucci, Maria; Tribalto, M; L. Vegna, M.; Dammacco, Franco; Pileri, Alessandro

doi:10.1056/nejm199005173222005

Public

Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy

Published in New England Journal of Medicine • May 17, 1990

Authors:

Franco Mandelli

Giuseppe Avvisati

Sergio Amadori

Abstract

The use of interferon for the induction treatment of multiple myeloma has been shown to be effective in about 20 percent of patients. We studied its effects on long-term survival when it was used for maintenance treatment. Between April 1985 and May 1988, 101 patients with symptomatic multiple myelo...

Subject

Medicine

Chemotherapy

Randomization

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!